Position in JNJ
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$6,881,063
-$422,070 QoQ
Shares Held
27,094
-9.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.38%
of 13F equity value
Holder Rank
#1,358
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Geneos Wealth Management Inc. holds $48,413,418 across 14 Drug Manufacturers - General names. JNJ ranks #3 (14.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
10,543 | $12,645,591 | |
| 2 | ABBV |
AbbVie Inc.
|
40,073 | $10,083,969 | |
| 3 | JNJ |
Johnson & Johnson
This page
|
27,094 | $6,881,063 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
46,311 | $5,850,931 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
94,459 | $5,442,727 | |
| 6 | AMGN |
Amgen Inc
|
7,107 | $2,573,586 | |
| 7 | MRK |
Merck & Co., Inc.
|
14,481 | $1,860,808 | |
| 8 | NVS |
Novartis AG
|
11,132 | $1,744,607 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,881,063 | 27,094 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $7,303,133 | 29,877 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $11,069,134 | 53,487 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $10,082,583 | 54,377 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $8,709,194 | 57,016 | Shares | Sole | 2025-08-18 | |
| 2025-03-31 | $13,247,630 | 79,882 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $8,965,283 | 61,992 | Shares | Sole | 2025-01-21 | |
| 2024-09-30 | $9,866,050 | 60,879 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $7,976,828 | 54,576 | Shares | Sole | 2024-07-23 | |
| 2024-03-31 | $5,604,988 | 35,432 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $5,626,339 | 35,896 | Shares | Sole | 2024-01-26 | |
| 2023-09-30 | $5,758,077 | 36,970 | Shares | Sole | 2023-10-11 | |
| 2023-06-30 | $5,879,601 | 35,522 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $5,254,965 | 33,903 | Shares | Sole | 2023-04-25 | |
| 2022-12-31 | $6,532,517 | 36,980 | Shares | Sole | 2023-01-31 | |
| 2022-09-30 | $5,910,691 | 36,182 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $11,247,033 | 63,360 | Shares | Sole | 2022-07-22 | |
| 2022-03-31 | $10,646,028 | 60,069 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $11,170,699 | 65,299 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $10,632,998 | 65,839 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $11,592,259 | 70,367 | Shares | Sole | 2021-07-08 | |
| 2021-03-31 | $12,518,868 | 76,172 | Shares | Sole | 2021-06-17 | |
| 2020-12-31 | $12,874,943 | 81,808 | Shares | Sole | 2021-05-19 | |
| 2020-09-30 | $11,043,322 | 74,176 | Shares | Sole | 2021-09-07 | |
| 2020-06-30 | $10,477,638 | 74,505 | Shares | Sole | 2021-09-07 | |
| 2020-03-31 | $9,215,685 | 70,279 | Shares | Sole | 2021-09-07 | |
| No filing history on record for this holder in this stock. | ||||||